5-(3′,4′-dihydroxyphenyl-γ-valerolactone), a major microbial metabolite of proanthocyanidin, attenuates THP-1 monocyte-endothelial adhesion

International Journal of Molecular Sciences

Volumn 18, Issue 7, 2017, Pages

  Lee, Charles C ^a   Kim, Jong Hun ^b   Kim, Ji Seung ^c   Oh, Yun Sil ^c   Han, Seung Min ^c   Park, Jung Han Yoon ^b   Lee, Ki Won ^b,c   Lee, Chang Yong ^a  

^a Cornell University ^*  (United States)

^b Seoul National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

5 (3 , 4 dihydroxyphenyl valerolactone); Atherosclerosis prevention; Monocyte endothelial adhesion; Proanthocyanidin microbial metabolite

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 (3′,4′ DIHYDROXYPHENYL GAMMA VALEROLACTONE); CATECHIN; DIHYDROCAFFEIC ACID; EPICATECHIN; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROANTHOCYANIDIN DERIVATIVE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; PROANTHOCYANIDIN; PROTECTIVE AGENT;

ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; CELL ADHESION ASSAY; CONTROLLED STUDY; DNA TRANSCRIPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; METABOLITE; MONOCYTE; MONOCYTE CULTURE; MTT ASSAY; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING; CELL COMMUNICATION; CELL LINE; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PROMOTER REGION;

CELL ADHESION; CELL COMMUNICATION; CELL LINE; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; PROANTHOCYANIDINS; PROMOTER REGIONS, GENETIC; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 85021335751     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18071363     Document Type: Article

References (43)

1. Woollard, K.J.; Geissmann, F. Monocytes in atherosclerosis: Subsets and functions. Nat. Rev. Cardiol. 2010, 7, 77–86.
2. McCullough, M.L.; Peterson, J.J.; Patel, R.; Jacques, P.F.; Shah, R.; Dwyer, J.T. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of us adults. Am. J. Clin. Nutr. 2012, 95, 454–464.
3. Wang, X.; Ouyang, Y.Y.; Liu, J.; Zhao, G. Flavonoid intake and risk of CVD: A systematic review and metaanalysis of prospective cohort studies. Br. J. Nutr. 2014, 111, 1–11.
4. Kay, C.D.; Hooper, L.; Kroon, P.A.; Rimm, E.B.; Cassidy, A. Relative impact of flavonoid composition, dose and structure on vascular function: A systematic review of randomised controlled trials of flavonoid-rich food products. Mol. Nutr. Food Res. 2012, 56, 1605–1616.
5. Hooper, L.; Kroon, P.A.; Rimm, E.B.; Cohn, J.S.; Harvey, I.; Le Cornu, K.A.; Ryder, J.J.; Hall, W.L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38–50.
6. Monagas, M.; Urpi-Sarda, M.; Sanchez-Patan, F.; Llorach, R.; Garrido, I.; Gomez-Cordoves, C.; Andres-Lacueva, C.; Bartolome, B. Insights into the metabolism and microbial biotransformation of dietary flavan- 3-ols and the bioactivity of their metabolites. Food Funct. 2010, 1, 233–253.
7. Ou, K.Q.; Gu, L.W. Absorption and metabolism of proanthocyanidins. J. Funct. Foods 2014, 7, 43–53.
8. Uhlenhut, K.; Hogger, P. Facilitated cellular uptake and suppression of inducible nitric oxide synthase by a metabolite of maritime pine bark extract (pycnogenol). Free Radic. Biol. Med. 2012, 53, 305–313.
9. Sanchez-Patan, F.; Barroso, E.; van de Wiele, T.; Jimenez-Giron, A.; Martin-Alvarez, P.J.; Moreno-Arribas, M.V.; Martinez-Cuesta, M.C.; Pelaez, C.; Requena, T.; Bartolome, B. Comparative in vitro fermentations of cranberry and grape seed polyphenols with colonic microbiota. Food Chem. 2015, 183, 273–282.
10. Appeldoorn, M.M.; Vincken, J.P.; Aura, A.M.; Hollman, P.C.H.; Gruppen, H. Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)- gamma-valerolactone as the major metabolites. J. Agric. Food Chem. 2009, 57, 1084–1092.
11. Unno, T.; Tamemoto, K.; Yayabe, F.; Kakuda, T. Urinary excretion of 5-(3′,4′-dihydroxyphenyl)-gammavalerolactone, a ring-fission metabolite of (−)-epicatechin, in rats and its in vitro antioxidant activity. J. Agric. Food Chem. 2003, 51, 6893–6898.
12. Urpi-Sarda, M.; Monagas, M.; Khan, N.; Llorach, R.; Lamuela-Raventos, R.M.; Jauregui, O.; Estruch, R.; Izquierdo-Pulido, M.; Andres-Lacueva, C. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216, 7258–7267.
13. Ottaviani, J.I.; Borges, G.; Momma, T.Y.; Spencer, J.P.E.; Keen, C.L.; Crozier, A.; Schroeter, H. The metabolome of [2-14C](−)-epicatechin in humans: Implications for the assessment of efficacy, safety, and mechanisms of action of polyphenolic bioactives. Sci. Rep. 2016, 6, 29034.
14. Rodriguez-Mateos, A.; Feliciano, R.P.; Boeres, A.; Weber, T.; Dos Santos, C.N.; Ventura, M.R.; Heiss, C. Cranberry (poly)phenol metabolites correlate with improvements in vascular function: A double-blind, randomized, controlled, dose-response, crossover study. Mol. Nutr. Food Res. 2016, 60, 2130–2140.
15. Li, C.; Lee, M.J.; Sheng, S.Q.; Meng, X.F.; Prabhu, S.; Winnik, B.; Huang, B.M.; Chung, J.Y.; Yan, S.Q.; Ho, C.T., et al. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol. 2000, 13, 177–184.
16. Bittner, K.; Kemme, T.; Peters, K.; Kersten, S.; Danicke, S.; Humpf, H.U. Systemic absorption and metabolism of dietary procyanidin b4 in pigs. Mol. Nutr. Food Res. 2014, 58, 2261–2273.
17. Stoupi, S.; Williamson, G.; Drynan, J.W.; Barron, D.; Clifford, M.N. A comparison of the in vitro biotransformation of (–)-epicatechin and procyanidin B2 by human faecal microbiota. Mol. Nutr. Food Res. 2010, 54, 747–759.
18. Wang, L.Q.; Meselhy, M.R.; Li, Y.; Nakamura, N.; Min, B.S.; Qin, G.W.; Hattori, M. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by eubacterium sp strain SDG-2, a human intestinal bacterium. Chem. Pharm. Bull. 2001, 49, 1640–1643.
19. Kutschera, M.; Engst, W.; Blaut, M.; Braune, A. Isolation of catechin-converting human intestinal bacteria. J. Appl. Microbiol. 2011, 111, 165–175.
20. Zampariello, C.A.; Mckay, D.L.; Dolnikowski, G.; Blumberg, J.; Chen, C.Y.O. Determination of cranberry proanthocyanidin A2 in human plasma and urine using LC-MS/MS. FASEB J. 2012, 26.
21. Sano, A.; Yamakoshi, J.; Tokutake, S.; Tobe, K.; Kubota, Y.; Kikuchi, M. Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci. Biotech. Bioch. 2003, 67, 1140–1143.
22. Holt, R.R.; Lazarus, S.A.; Sullards, M.C.; Zhu, Q.Y.; Schramm, D.D.; Hammerstone, J.F.; Fraga, C.G.; Schmitz, H.H.; Keen, C.L. Procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 2002, 76, 798–804.
23. Richelle, M.; Tavazzi, I.; Enslen, M.; Offord, E.A. Plasma kinetics in man of epicatechin from black chocolate. Eur. J. Clin. Nutr. 1999, 53, 22–26.
24. Saura-Calixto, F.; Perez-Jimenez, J.; Tourino, S.; Serrano, J.; Fuguet, E.; Torres, J.L.; Goni, I. Proanthocyanidin metabolites associated with dietary fibre from in vitro colonic fermentation and proanthocyanidin metabolites in human plasma. Mol. Nutr. Food Res. 2010, 54, 939–946.
25. Bartolome, B.; Monagas, M.; Garrido, I.; Gomez-Cordoves, C.; Martin-Alvarez, P.J.; Lebron-Aguilar, R.; Urpi-Sarda, M.; Llorach, R.; Andres-Lacueva, C. Almond (Prunus dulcis (Mill.) D.A. Webb) polyphenols: From chemical characterization to targeted analysis of phenolic metabolites in humans. Arch. Biochem. Biophys. 2010, 501, 124–133.
26. Serra, A.; Macia, A.; Romero, M.P.; Reguant, J.; Ortega, N.; Motilva, M.J. Metabolic pathways of the colonic metabolism of flavonoids (flavonols, flavones and flavanones) and phenolic acids. Food Chem. 2012, 130, 383–393.
27. Urpi-Sarda, M.; Monagas, M.; Khan, N.; Lamuela-Raventos, R.M.; Santos-Buelga, C.; Sacanella, E.; Castell, M.; Permanyer, J.; Andres-Lacueva, C. Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats. Anal. Bioanal. Chem. 2009, 394, 1545–1556.
28. Grimm, T.; Skrabala, R.; Chovanova, Z.; Muchova, J.; Sumegova, K.; Liptakova, A.; Durackova, Z.; Hogger, P. Single and multiple dose pharmacokinetics of maritime pine bark extract (pycnogenol) after oral administration to healthy volunteers. BMC Clin. Pharmacol. 2006, 6, 4.
29. Grimm, T.; Schafer, A.; Hogger, P. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Free Radic. Biol. Med. 2004, 36, 811–822.
30. World Health Organization; World Heart Federation; World Stroke Organization. Global Atlas on Cardiovascular Disease Prevention and Control; Mendis, S., Puska, P., Norrving, B., Eds.; World Health Organization in Collaboration with the World Heart Federation and the World Stroke Organization: Geneva, Switzerland, 2011; p. vi, 155p.
31. Ross, R. Atherosclerosis—An inflammatory disease. N. Engl. J. Med. 1999, 340, 115–126.
32. Libby, P.; Ridker, P.M.; Maseri, A. Inflammation and atherosclerosis. Circulation 2002, 105, 1135–1143.
33. Libby, P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 2006, 83, S456–S460.
34. Tedgui, A.; Mallat, Z. Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol. Rev. 2006, 86, 515–581.
35. Binion, D.G.; Heidemann, J.; Li, M.S.; Nelson, V.M.; Otterson, M.F.; Rafiee, P. Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3- kinase/Akt/MAPK/NF-κB: Inhibitory role of curcumin. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297, G259–G268.
36. Monagas, M.; Khan, N.; Andres-Lacueva, C.; Casas, R.; Urpi-Sarda, M.; Llorach, R.; Lamuela-Raventos, R.M.; Estruch, R. Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am. J. Clin. Nutr. 2009, 90, 1144–1150.
37. Wang-Polagruto, J.F.; Villablanca, A.C.; Polagruto, J.A.; Lee, L.; Holt, R.R.; Schrader, H.R.; Ensunsa, J.L.; Steinberg, F.M.; Schmitz, H.H.; Keen, C.L. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hype cholesterolemic postmenopausal women. J. Cardiovasc. Pharmacol. 2006, 47, S177-S186.
38. Zhang, Z.F.; Li, Y.J.; Li, Y. Grape seed proanthocyanidin extracts prevent hyperglycemia-induced monocyte adhesion to aortic endothelial cells and ameliorates vascular inflammation in high-carbohydrate/high-fat diet and streptozotocin-induced diabetic rats. Int. J. Food Sci. Nutr. 2016, 67, 524–534.
39. Mohana, T.; Navin, A.V.; Jamuna, S.; Sadullah, M.S.S.; Devaraj, S.N. Inhibition of differentiation of monocyte to macrophages in atherosclerosis by oligomeric proanthocyanidins—In vivo and in vitro study. Food Chem. Toxicol. 2015, 82, 96–105.
40. Sen, C.K.; Bagchi, D. Regulation of inducible adhesion molecule expression in human endothelial cells by grape seed proanthocyanidin extract. Mol. Cell. Biochem. 2001, 216, 1–7.
41. Claude, S.; Boby, C.; Rodriguez-Mateos, A.; Spencer, J.P.E.; Gerard, N.; Morand, C.; Milenkovic, D. Flavanol metabolites reduce monocyte adhesion to endothelial cells through modulation of expression of genes via p38-MAPK and p65-NF-κB pathways. Mol. Nutr. Food Res. 2014, 58, 1016–1027.
42. Koga, T.; Meydani, M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am. J. Clin. Nutr. 2001, 73, 941–948.
43. Grimm, T.; Chovanova, Z.; Muchova, J.; Sumegova, K.; Liptakova, A.; Durackova, Z.; Hogger, P. Inhibition of NF-κB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (pycnogenol). J. Inflamm. 2006, 3, 1.